In much of the world (but not in the U.S.,) drug-coated stents are avoided by cardiologists because of their high cost. To compensate for the inability to use these stents, many cardiologists outside of the U.S. have taken to administering sirolimus (also
C. Wu, L. Huang, and L. Kang. Proceedings of 2005 International Conference on
Machine Learning and Cybernetics, 5, page 2870--2873. IEEE, (18-21 August 2005)